Skip to content
10-Q

Quarterly Report

AVADEL PHARMACEUTICALS PLC

0001012477-25-000031

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 97.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 101.28M sh
Shares Diluted Q3 2025 · Sep 30, 2025 99.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 94.72M sh
Capex Q3 2025 · Sep 30, 2025 $190K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 $26.67M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$54.78M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $79.81M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $51.37M
Stockholders Equity Q3 2025 · Sep 30, 2025 $98.23M
Stockholders Equity Q3 2025 · Jun 30, 2025 $90.71M
Stockholders Equity Q3 2025 · Mar 31, 2025 $74.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $73.85M
Stockholders Equity Q3 2025 · Sep 30, 2024 $74.66M
Stockholders Equity Q3 2025 · Jun 30, 2024 $70.29M
Stockholders Equity Q3 2025 · Mar 31, 2024 $78.38M
Stockholders Equity Q3 2025 · Dec 31, 2023 $87.74M
Current Liabilities Q3 2025 · Sep 30, 2025 $62.49M
Current Liabilities Q3 2025 · Dec 31, 2024 $48.83M
Total Liabilities Q3 2025 · Sep 30, 2025 $101.22M
Total Liabilities Q3 2025 · Dec 31, 2024 $90.39M
Current Assets Q3 2025 · Sep 30, 2025 $172.23M
Current Assets Q3 2025 · Dec 31, 2024 $134.21M
Total Assets Q3 2025 · Sep 30, 2025 $199.45M
Total Assets Q3 2025 · Dec 31, 2024 $164.24M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 $0.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.03
Eps Basic Q3 2025 · Sep 30, 2024 −$0.46
Sga Expense Q3 2025 · Sep 30, 2025 $52.64M
Sga Expense Q3 2025 · Sep 30, 2025 $146.84M
Sga Expense Q3 2025 · Sep 30, 2024 $40.39M
Sga Expense Q3 2025 · Sep 30, 2024 $136.42M
Rd Expense Q3 2025 · Sep 30, 2025 $27.01M
Rd Expense Q3 2025 · Sep 30, 2025 $35.62M
Rd Expense Q3 2025 · Sep 30, 2024 $3.8M
Rd Expense Q3 2025 · Sep 30, 2024 $10.92M
Net Income Q3 2025 · Sep 30, 2025 $20K
Net Income Q3 2025 · Sep 30, 2025 $4.77M
Net Income Q3 2025 · Jun 30, 2025 $9.67M
Net Income Q3 2025 · Mar 31, 2025 −$4.92M
Net Income Q3 2025 · Sep 30, 2024 −$2.63M
Net Income Q3 2025 · Sep 30, 2024 −$43.79M
Net Income Q3 2025 · Jun 30, 2024 −$13.82M
Net Income Q3 2025 · Mar 31, 2024 −$27.34M
Operating Income Q3 2025 · Sep 30, 2025 $1.94M
Operating Income Q3 2025 · Sep 30, 2025 $7.82M
Operating Income Q3 2025 · Sep 30, 2024 −$327K
Operating Income Q3 2025 · Sep 30, 2024 −$39.1M
Gross Profit Q3 2025 · Sep 30, 2025 $81.58M
Gross Profit Q3 2025 · Sep 30, 2025 $190.28M
Gross Profit Q3 2025 · Sep 30, 2024 $43.87M
Gross Profit Q3 2025 · Sep 30, 2024 $108.24M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $7.83M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $6.16M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $10.47M
Revenue Q3 2025 · Sep 30, 2025 $77.47M
Revenue Q3 2025 · Sep 30, 2025 $198.11M
Revenue Q3 2025 · Sep 30, 2024 $50.03M
Revenue Q3 2025 · Sep 30, 2024 $118.71M